However, the combined use of STAT3 inhibitors with PI3K/AKT/mTOR inhibitors can synergistically induce apoptosis in PTEN-deficient cancer cell lines, highlighting the potential of this combined therapeutic strategy in the treatment of PTEN-deficient tumors, including gastric cancer [53]. The gene discussed is AKT1; the disease is gastric cancer.